ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other ...
Higher ApoB/ApoA1 ratio was linked to cardiovascular complications but did not improve predictive value of current models. Higher apolipoprotein B to A1 (ApoB/ApoA1) ratio is linked to both major ...
reacts with both free human Apo-A1 and high density lipoprotein (HDL) bearing Apo-A1, but does not cross-react with ApoE, ApoB or Albumin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results